4//SEC Filing
Koenig Sheldon L. 4
Accession 0001628280-22-025217
CIK 0001434868other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:08 PM ET
Size
5.0 KB
Accession
0001628280-22-025217
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2022-09-19$6.94/sh−3,394$23,548→ 198,257 total
Footnotes (2)
- [F1]Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.
- [F2]Consists of 198,257 shares of common stock held, including 2,880 shares acquired in Esperion's Employee Stock Purchase Plan on August 31, 2022.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001766524
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 4:08 PM ET
- Size
- 5.0 KB